Palantir's US Commercial Surge Heightens Valuation Scrutiny

What happened

Palantir reported Q2 2026 revenue of $1.9 billion, up 93% year over year, with US commercial revenue surging 149% to $764 million, prompting management to raise 2026 US commercial revenue guidance to at least $3.424 billion (134% growth) and adjusted free cash flow to $4.5–$4.7 billion. The new Seeking Alpha article frames this as the next bull leg, but the DeepValue report cautions that the stock at $171.5 already prices in continued hypergrowth, durable defense funding, and sustained premium margins, with P/E of 136.1 and EV/EBITDA of 232.9. Crucially, much of the demand is reflected in remaining deal value (RDV) of $6.238 billion, which includes cancelable contracts, whereas noncancelable RPO is only $4.9 billion with just 43% expected within 12 months. Additionally, 52% of first-half revenue came from government customers, and the company itself warns that current US government spending levels may not be sustained. Thus, while the commercial acceleration is real, the market has already discounted a very strong future, leaving little room for error in converting option-heavy bookings into durable recognized revenue.

Implication

The near-term risk-reward is skewed because the current valuation implies flawless execution; any miss on revenue conversion or government spending could trigger a sharp derating. The next quarterly release must show growth in recognized US commercial revenue, contract liabilities, and noncancelable RPO, not just headline RDV. Maven's program-of-record status needs to translate into funded government deployments to offset the inherent cancellability of many contracts. Additionally, elevated stock-based compensation and a $5.6 billion cloud commitment through 2036 add pressure to future per-share value. Until the stock pulls back toward the $145 attractive entry or until two consecutive quarters show RDV converting into durable backlog, a wait-and-see approach remains prudent.

Thesis delta

No material shift: the thesis remains WAIT due to extreme valuation despite accelerating growth. The article's bullish narrative is consistent with existing data but does not resolve the bear case around contract quality and government dependence.